Who gets adjuvant treatment for stage II and III rectal cancer? Insight from surveillance, epidemiology, and end results-medicare Academic Article uri icon

Overview

MeSH Major

  • Medicare
  • Patient Selection
  • Practice Patterns, Physicians'
  • Rectal Neoplasms

abstract

  • Because pelvic recurrences are a substantial cause of morbidity, further efforts are needed to ensure that elderly patients have the opportunity to make informed decisions regarding adjuvant treatment.

publication date

  • September 2001

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 11533092

Additional Document Info

start page

  • 3712

end page

  • 8

volume

  • 19

number

  • 17